They investigated about null and rare APOC3 variants and the correlation with TG levels and CAD; some variants have shown different effects in different patients, and even though the plasma TG levels mean was significantly lower among the carriers of the variant allele vs. wild type, none of these variants exhibited any significant protection against CAD except for the rs138326449 [27]. This evidence concerns the gene APOC3 and coronary artery disorder.